GALNT6 and metastatic malignant neoplasm in the lymph nodes: The gene expression data and consecutive functional enrichment and network analysis further support the data obtained by the clinicopathological characteristics, showing that high GALNT6 expression correlates with increased recurrence, lymph node metastasis, and chemoresistance.